Impact of Prevention and Treatment Programmes
The present value of the avoided costs less the cost of the treatment programme.
The present value of the avoided costs less the cost of the prevention programme.
Life expectancy of HIV-positive employees is extended (productive time in the workplace is extended and the costs associated with death are deferred).
Absenteeism is reduced and productivity improves.
Medical expenses as a result of the treatment of opportunistic infections falls.
New HIV incidence rate falls (new infections are avoided).
The cost of a first-line drug regimen for all HIV-positive employees.
Modelled simply as a fixed amount per employee in the workplace.
Antiretroviral treatment for HIV positive employees.
Information, Education and Communication (IEC), provision of condoms etc.
Non-financial benefits of workplace interventions: additional benefits might accrue as drug prices fall, new treatments are developed and public infrastructure to treat HIV/AIDS expands; municipality buys time to expand and implement responses; impact on employee morale, institutional memory; labour relations